RxSight, Inc. NASDAQ:RXST

RxSight stock price today

$8.6
-25.61
-74.87%
Financial Health
0
1
2
3
4
5
6
7
8
9

RxSight stock price monthly change

-28.29%
month

RxSight stock price quarterly change

-28.29%
quarter

RxSight stock price yearly change

-16.33%
year

RxSight key metrics

Market Cap
1.38B
Enterprise value
469.88M
P/E
-7.31
EV/Sales
9.58
EV/EBITDA
-8.13
Price/Sales
9.73
Price/Book
5.30
PEG ratio
-1.04
EPS
-1.26
Revenue
109.56M
EBITDA
-41.04M
Income
-44.49M
Revenue Q/Q
68.74%
Revenue Y/Y
90.38%
Profit margin
-136.22%
Oper. margin
-129.21%
Gross margin
43.52%
EBIT margin
-129.21%
EBITDA margin
-37.46%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

RxSight stock price history

RxSight stock forecast

RxSight financial statements

Average Price Target
Last Year

$68.13

Potential upside: 692.15%

Based on estimate of 7 analysts
  • Analysts Price target

  • Financials & Ratios estimates

RxSight, Inc. (NASDAQ:RXST): Profit margin
Jun 2023 20.81M -13.80M -66.33%
Sep 2023 30.66M -12.41M -40.48%
Dec 2023 28.58M -9.17M -32.11%
Mar 2024 29.51M -9.1M -30.83%
RxSight, Inc. (NASDAQ:RXST): Earnings per share (EPS)
2024-02-28 -0.36 -0.26
2024-05-06 -0.17 -0.12
RxSight, Inc. (NASDAQ:RXST): Debt to assets
Jun 2023 195261000 38.07M 19.5%
Sep 2023 181850000 20.37M 11.2%
Dec 2023 182550000 22.18M 12.15%
Mar 2024 183165000 19.23M 10.5%
RxSight, Inc. (NASDAQ:RXST): Cash Flow
Jun 2023 -7.54M 4.39M 891K
Sep 2023 -7.98M 17.27M -8.23M
Dec 2023 -9.88M 4.56M 5.15M
Mar 2024 -9.30M 24.27M 7.99M

RxSight alternative data

RxSight, Inc. (NASDAQ:RXST): Employee count
Aug 2023 292
Sep 2023 292
Oct 2023 292
Nov 2023 292
Dec 2023 292
Jan 2024 292
Feb 2024 292
Mar 2024 374
Apr 2024 374
May 2024 374
Jun 2024 374
Jul 2024 374

RxSight other data

25.48% -9.26%
of RXST is owned by hedge funds
7.04M -2.56M
shares is hold by hedge funds

RxSight, Inc. (NASDAQ:RXST): Insider trades (number of shares)
Period Buy Sel
Dec 2023 0 160437
Jan 2024 0 197839
Feb 2024 8000 105744
Mar 2024 0 10000
Apr 2024 0 20000
May 2024 5000 50000
Jun 2024 0 15625
Jul 2024 0 18402
Aug 2024 0 9000
Sep 2024 0 15505
Oct 2024 0 49115
Nov 2024 22476 28592
Transaction Date Insider Security Shares Price per share Total value Source
Option
GOLDSHLEGER ILYA officer: See remarks
Common Stock 3,105 $15.08 $46,823
Sale
GOLDSHLEGER ILYA officer: See remarks
Common Stock 3,105 $46.08 $143,078
Option
GOLDSHLEGER ILYA officer: See remarks
Stock Option (right to buy) 3,105 $15.08 $46,823
Sale
MANIAR SHWETA director
Common Stock 3,782 $45.88 $173,518
Option
GOLDSHLEGER ILYA officer: See remarks
Common Stock 3,100 $15.08 $46,748
Option
GOLDSHLEGER ILYA officer: See remarks
Stock Option (right to buy) 3,100 $15.08 $46,748
Sale
GOLDSHLEGER ILYA officer: See remarks
Common Stock 3,100 $45.88 $142,228
Option
GOLDSHLEGER ILYA officer: See remarks
Stock Option (right to buy) 3,100 $15.08 $46,748
Sale
GOLDSHLEGER ILYA officer: See remarks
Common Stock 3,100 $45 $139,500
Option
GOLDSHLEGER ILYA officer: See remarks
Stock Option (right to buy) 3,100 $15.08 $46,748
Insider Compensation
Dr. Ronald M. Kurtz M.D. (1963) Pres, Chief Executive Officer & Director
$336,580
Dr. Ilya Goldshleger Ph.D. (1975) Chief Operating Officer
$332,090
Mr. Eric J. Weinberg (1961) Chief Commercial Officer
$317,600
Ms. Shelley B. Thunen (1954) Chief Financial Officer & Assistant Sec. $295,510
Thursday, 19 December 2024
https://thefly.com
Tuesday, 17 December 2024
https://thefly.com
Friday, 29 November 2024
seekingalpha.com
Wednesday, 20 November 2024
zacks.com
Saturday, 9 November 2024
seekingalpha.com
Thursday, 7 November 2024
zacks.com
Thursday, 24 October 2024
globenewswire.com
Thursday, 22 August 2024
globenewswire.com
Tuesday, 13 August 2024
seekingalpha.com
Monday, 12 August 2024
zacks.com
Monday, 5 August 2024
seekingalpha.com
zacks.com
globenewswire.com
investorplace.com
Monday, 29 July 2024
zacks.com
Monday, 22 July 2024
globenewswire.com
Friday, 12 July 2024
zacks.com
Wednesday, 5 June 2024
globenewswire.com
Tuesday, 28 May 2024
zacks.com
Thursday, 23 May 2024
zacks.com
Monday, 13 May 2024
globenewswire.com
Wednesday, 8 May 2024
globenewswire.com
Monday, 6 May 2024
Seeking Alpha
Monday, 22 April 2024
GlobeNewsWire
Wednesday, 28 February 2024
Seeking Alpha
Wednesday, 14 February 2024
GlobeNewsWire
Friday, 12 January 2024
InvestorPlace
Wednesday, 27 December 2023
GlobeNewsWire
Sunday, 12 November 2023
Seeking Alpha
Friday, 27 October 2023
Seeking Alpha
  • What's the price of RxSight stock today?

    One share of RxSight stock can currently be purchased for approximately $8.6.

  • When is RxSight's next earnings date?

    Unfortunately, RxSight's (RXST) next earnings date is currently unknown.

  • Does RxSight pay dividends?

    No, RxSight does not pay dividends.

  • How much money does RxSight make?

    RxSight has a market capitalization of 1.38B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 81.77% to 89.08M US dollars. RxSight made a loss 48.61M US dollars in net income (profit) last year or -$0.12 on an earnings per share basis.

  • What is RxSight's stock symbol?

    RxSight, Inc. is traded on the NASDAQ under the ticker symbol "RXST".

  • What is RxSight's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of RxSight?

    Shares of RxSight can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are RxSight's key executives?

    RxSight's management team includes the following people:

    • Dr. Ronald M. Kurtz M.D. Pres, Chief Executive Officer & Director(age: 62, pay: $336,580)
    • Dr. Ilya Goldshleger Ph.D. Chief Operating Officer(age: 50, pay: $332,090)
    • Mr. Eric J. Weinberg Chief Commercial Officer(age: 64, pay: $317,600)
    • Ms. Shelley B. Thunen Chief Financial Officer & Assistant Sec.(age: 71, pay: $295,510)
  • How many employees does RxSight have?

    As Jul 2024, RxSight employs 374 workers.

  • When RxSight went public?

    RxSight, Inc. is publicly traded company for more then 4 years since IPO on 30 Jul 2021.

  • What is RxSight's official website?

    The official website for RxSight is rxsight.com.

  • Where are RxSight's headquarters?

    RxSight is headquartered at 100 Columbia, Aliso Viejo, CA.

  • How can i contact RxSight?

    RxSight's mailing address is 100 Columbia, Aliso Viejo, CA and company can be reached via phone at +94 95217830.

  • What is RxSight stock forecast & price target?

    Based on 7 Wall Street analysts` predicted price targets for RxSight in the last 12 months, the avarage price target is $68.13. The average price target represents a 692.15% change from the last price of $8.6.

RxSight company profile:

RxSight, Inc.

rxsight.com
Exchange:

NASDAQ

Full time employees:

374

Industry:

Medical - Devices

Sector:

Healthcare

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

100 Columbia
Aliso Viejo, CA 92656

CIK: 0001111485
ISIN: US78349D1072
CUSIP: 78349D107